MRNA Jun 2025 75.000 put
| Previous close | 6.3000 |
| Open | 4.9000 |
| Bid | 4.4500 |
| Ask | 4.7000 |
| Strike | 75.00 |
| Expiry date | 2025-06-20 |
| Day's range | 4.9000 - 4.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 99 |
- Yahoo Finance Video
Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
Pharmaceutical stocks Novo Nordisk (NVO) and Moderna (MRNA) are trending in opposite directions following their earnings reports. Despite topping Wall Street's profit expectations, Novo Nordisk shares are sinking as the company fell short of estimates for its popular GLP-1 weight-loss drug, Wegovy. Meanwhile, Moderna is on the rise even after reporting first quarter losses. Moderna's growth is largely due to an uptick in coronavirus boosters and an expansion into the Brazillian market. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
Investor's Business DailyIs Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Moderna stock broke out of a cup-with-handle base after its first-quarter sales and earnings report. Is MRNA stock a buy right now?
Investor's Business DailyModerna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Moderna stock broke out for the first time in a year Thursday after beating first-quarter expectations as its second potential approval looms.
